These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3101672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
    Kloprogge E, Mommersteeg M, Akkerman JW.
    J Biol Chem; 1986 Aug 25; 261(24):11071-6. PubMed ID: 3015954
    [Abstract] [Full Text] [Related]

  • 3. Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.
    Kloprogge E, Akkerman JW.
    Biochem J; 1984 Nov 01; 223(3):901-9. PubMed ID: 6150705
    [Abstract] [Full Text] [Related]

  • 4. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA.
    Krishnamurthi S, Joseph S, Kakkar VV.
    Biochim Biophys Acta; 1987 Mar 11; 927(3):429-36. PubMed ID: 3101746
    [Abstract] [Full Text] [Related]

  • 5. Stimulus-aggregation coupling in platelets activated with PAF-acether.
    Kloprogge E, Hasselaar P, Gorter G, Akkerman JW.
    Biochim Biophys Acta; 1986 Aug 06; 883(1):127-37. PubMed ID: 3089297
    [Abstract] [Full Text] [Related]

  • 6. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP, Watts IS.
    Br J Pharmacol; 1982 Apr 06; 75(4):623-31. PubMed ID: 6802211
    [Abstract] [Full Text] [Related]

  • 7. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
    Ostermann G, Till U, Thielmann K.
    Thromb Res; 1984 Feb 15; 33(4):409-18. PubMed ID: 6710440
    [Abstract] [Full Text] [Related]

  • 8. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F, Vargaftig BB.
    Br J Pharmacol; 1984 Nov 15; 83(3):625-33. PubMed ID: 6439269
    [Abstract] [Full Text] [Related]

  • 9. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
    Vargaftig BB, Fouque F, Benveniste J, Odiot J.
    Thromb Res; 1982 Nov 15; 28(4):557-73. PubMed ID: 7164036
    [Abstract] [Full Text] [Related]

  • 10. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.
    Kloprogge E, Hasselaar P, Akkerman JW.
    Biochem J; 1986 Sep 15; 238(3):885-91. PubMed ID: 3800968
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
    Bennett JS, Vilaire G, Burch JW.
    J Clin Invest; 1981 Oct 15; 68(4):981-7. PubMed ID: 6270196
    [Abstract] [Full Text] [Related]

  • 13. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
    Honey AC, Lad N, Tuffin DP.
    Thromb Haemost; 1986 Aug 20; 56(1):80-5. PubMed ID: 3775692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB, Joseph D, Marlas G, Chevance LG.
    Thromb Haemost; 1982 Aug 24; 48(1):67-71. PubMed ID: 7135345
    [Abstract] [Full Text] [Related]

  • 16. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M, Canciani MT, Mannucci PM.
    Thromb Haemost; 1985 Apr 22; 53(2):221-4. PubMed ID: 3927505
    [Abstract] [Full Text] [Related]

  • 17. Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets.
    Tuffin DP, Davey P, Dyer RL, Lunt DO, Wade PJ.
    Adv Exp Med Biol; 1985 Apr 22; 192():83-96. PubMed ID: 3834789
    [Abstract] [Full Text] [Related]

  • 18. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
    Simon MF, Chap H, Braquet P, Douste-Blazy L.
    Thromb Res; 1987 Feb 15; 45(4):299-309. PubMed ID: 3576518
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
    Iñarrea P, Gomez-Cambronero J, Nieto M, Crespo MS.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):309-15. PubMed ID: 6510472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.